CD8A and neoplasm: Meanwhile, the percentage of IFN‐γ+CD8+ T cells was the highest in the sgCas9‐AdV/Gel‐treated group (Figure 4D and Figure S15, Supporting Information), thus potentiating the adaptive immune response for tumor control.